Schimmelt 2
Eindhoven NL-5656
Netherlands
https://www.onwd.com
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 99
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. David L. Marver | CEO & Executive Director | 767k | S.O. | 1968 |
Dr. Gregoire Courtine Ph.D. | Chief Scientific Officer & Director | S.O. | S.O. | 1975 |
Mr. Khaled Bahi | Interim Chief Financial Officer | S.O. | S.O. | 1966 |
Mr. Robert W. Odell | Vice President of Operations | S.O. | S.O. | 1960 |
Mr. John Murphy | Chief Technology Officer | S.O. | S.O. | S.O. |
Ms. Sarah Moore | Vice President of Global Marketing | S.O. | S.O. | S.O. |
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
L’ISS Governance QualityScore de Onward Medical N.V. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..